Expeditious Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 0.75 M
- Company Age 9 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.50 M
- Revenue Growth -47.81%
- Profit Growth -48.96%
- Ebitda -86.88%
- Net Worth -54.77%
- Total Assets 10.81%
About Expeditious Diagnostics
Expeditious Diagnostics Private Limited (EDPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 September 2015 (Nine years and four months 25 days old ). Its registered office is in Pali, Rajasthan, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.75 M.
The company currently has active open charges totaling ₹6.50 M.
Prashant Toraskar, Sanjeev Parakh, Narendra Parakh, and One other member serve as directors at the Company.
Company Details
-
Location
Pali, Rajasthan, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U85100RJ2015PTC048300
-
Company No.
048300
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
21 Sep 2015
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Jaipur
Industry
Who are the key members and board of directors at Expeditious Diagnostics?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prashant Toraskar
|
Director | 21-Sep-2015 | Current |
|
Sanjeev Parakh
|
Director | 21-Sep-2015 | Current |
|
Narendra Parakh
|
Director | 21-Sep-2015 | Current |
|
Naresh Gupta
|
Director | 21-Sep-2015 | Current |
Financial Performance of Expeditious Diagnostics.
Expeditious Diagnostics Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 47.81% decrease. The company also saw a substantial fall in profitability, with a 48.96% decrease in profit. The company's net worth observed a substantial decline by a decrease of 54.77%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Expeditious Diagnostics?
In 2019, Expeditious Diagnostics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Kabs Healthcare Private LimitedPrashant Toraskar is a mutual person
-
Parakh Stones Private LimitedSanjeev Parakh and Narendra Parakh are mutual person
Charges (Loans)
₹6.50 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.65 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Mar 2016 | Others | ₹6.50 M | Open |
How Many Employees Work at Expeditious Diagnostics?
Unlock and access historical data on people associated with Expeditious Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Expeditious Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Expeditious Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.